These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22272687)

  • 21. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and pharmacodynamics in the critically ill patient.
    Park GR
    Xenobiotica; 1993 Nov; 23(11):1195-230. PubMed ID: 8310706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
    Mey C; Hentschel H; Hippius M; Balogh A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase.
    Sandberg L; Taavola H; Aoki Y; Chandler R; Norén GN
    Drug Saf; 2020 Oct; 43(10):999-1009. PubMed ID: 32564242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologically based pharmacokinetic modeling at the extremes of age.
    Johnston C; Kirkpatrick CM; McLachlan AJ; Hilmer SN
    Clin Pharmacol Ther; 2013 Feb; 93(2):148. PubMed ID: 23169431
    [No Abstract]   [Full Text] [Related]  

  • 26. Basic principles of pharmacologic action.
    Schwertz DW
    Nurs Clin North Am; 1991 Jun; 26(2):245-62. PubMed ID: 2047284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradoxical Reactions to Biologic Therapy in Psoriasis: A Review of the Literature.
    Munera-Campos M; Ballesca F; Carrascosa JM
    Actas Dermosifiliogr (Engl Ed); 2018 Nov; 109(9):791-800. PubMed ID: 29903464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others.
    Puig L
    Curr Probl Dermatol; 2018; 53():49-63. PubMed ID: 29131037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T
    ACS Chem Biol; 2009 Apr; 4(4):249-60. PubMed ID: 19193052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology for the geriatric surgical patient.
    Then J; Tisherman SA
    Surg Clin North Am; 2015 Feb; 95(1):139-47. PubMed ID: 25459548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Feasibility Study of Drug-Drug Interaction Signal Detection in Regular Pharmacovigilance.
    Hult S; Sartori D; Bergvall T; Hedfors Vidlin S; Grundmark B; Ellenius J; Norén GN
    Drug Saf; 2020 Aug; 43(8):775-785. PubMed ID: 32681439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of drugs upon testimony.
    Lader M
    Med Sci Law; 1999 Apr; 39(2):99-105. PubMed ID: 10332156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of stereochemical aspects on drug interaction in pharmacokinetics.
    Zhou Q; Yao TW; Zeng S
    Acta Pharmacol Sin; 2002 May; 23(5):385-92. PubMed ID: 11978187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medications in older patients.
    Hobson M
    West J Med; 1992 Nov; 157(5):539-43. PubMed ID: 1309183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3D pharmacophoric similarity improves multi adverse drug event identification in pharmacovigilance.
    Vilar S; Tatonetti NP; Hripcsak G
    Sci Rep; 2015 Mar; 5():8809. PubMed ID: 25744369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse drug reactions in older adults: a retrospective study from pharmacovigilance.
    Charfi R; El Aïdli S; Zaïem A; Kastalli S; Sraïri S; Daghfous R; Lakhal M
    Therapie; 2012; 67(5):471-6. PubMed ID: 23241257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Completeness of published case reports on suspected adverse drug reactions: evaluation of 100 reports from a company safety database.
    Impicciatore P; Mucci M
    Drug Saf; 2010 Sep; 33(9):765-73. PubMed ID: 20701409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interest of pharmacoepidemiology for pharmacodynamics and analysis of the mechanism of action of drugs.
    Lapeyre-Mestre M; Montastruc F
    Therapie; 2019 Apr; 74(2):209-214. PubMed ID: 30792079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.